The Effects of Thrombocytopenia on the Activated Coagulation Time
Authors:
- Tameshwar AmmarTATameshwar Ammar
- Cherie F. FisherCFCherie F. Fisher
- Kaya SarierKSKaya Sarier
- Barry S. CollerBCBarry S. Coller
- 1 December 1996
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 83 (6) , 1185-1188
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)The American Journal of Cardiology, 1995
- Modulation of Platelet Surface Adhesion Receptors during Cardiopulmonary BypassAnesthesiology, 1991
- Limit(ation)s for ACTAnesthesia & Analgesia, 1989
- Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.Journal of Clinical Investigation, 1986
- Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal CircuitsSeminars in Thrombosis and Hemostasis, 1985
- Use of the Activated Coagulation Time in Cardiac Surgery:Effects on Heparin-Protamine Dosages and BleedingScandinavian Journal of Thoracic and Cardiovascular Surgery, 1981
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978
- A Study of Platelet Counts During Cardiopulmonary BypassTransfusion, 1972
- Activated coagulation time of whole bloodJAMA, 1966
- A CLINICAL STUDY OF THE COAGULATION TIME OF BLOODThe American Journal of the Medical Sciences, 1913